EWS may exploit the same mechanisms of potentiation of oncogenic signaling demonstrated in AML as the activity of these receptors may be enhanced by interaction with IL-1RAP, which is also highly expressed in EWS. The gene discussed is IL1RAP; the disease is acute myeloid leukemia.